Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Glynn

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Anesthesiology|December 1, 1989
Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypassV J Zulys, S J Teasdale, E R Michel, et al.
Anesthesiology|November 1, 1996
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantationJ F Boylan, J R Klinck, A N Sandler, et al.
Plos Biology|August 17, 2004
Genome-wide mapping of the cohesin complex in the yeast Saccharomyces cerevisiaeEarl F Glynn, Paul C Megee, Hong-Guo Yu, et al.
Transplantation|July 9, 2020
Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver DiseaseMichelle H Kim, Ailene Nguyen, Mary Lo, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 17, 1998
The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C)J M Karski, N P Dowd, R Joiner, et al.
Transplantation Proceedings|February 1, 1989
Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survivalP D Greig, G M Woolf, M Abecassis, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1991
A reevaluation of heparin requirements for cardiopulmonary bypassP F Cardoso, F Yamazaki, S Keshavjee, et al.
Transplantation Proceedings|April 1, 1989
Prostaglandin E1 for primary nonfunction following liver transplantationP D Greig, G M Woolf, M Abecassis, et al.
Transplantation|September 1, 1989
Treatment of primary liver graft nonfunction with prostaglandin E1P D Greig, G M Woolf, S B Sinclair, et al.
The Journal of Surgical Research|June 1, 1987
Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegiaK H Teoh, G T Christakis, R D Weisel, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Anesthesiology|December 1, 1989
Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypassV J Zulys, S J Teasdale, E R Michel, et al.
Anesthesiology|November 1, 1996
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantationJ F Boylan, J R Klinck, A N Sandler, et al.
Plos Biology|August 17, 2004
Genome-wide mapping of the cohesin complex in the yeast Saccharomyces cerevisiaeEarl F Glynn, Paul C Megee, Hong-Guo Yu, et al.
Transplantation|July 9, 2020
Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver DiseaseMichelle H Kim, Ailene Nguyen, Mary Lo, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 17, 1998
The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C)J M Karski, N P Dowd, R Joiner, et al.
Transplantation Proceedings|February 1, 1989
Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survivalP D Greig, G M Woolf, M Abecassis, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1991
A reevaluation of heparin requirements for cardiopulmonary bypassP F Cardoso, F Yamazaki, S Keshavjee, et al.
Transplantation Proceedings|April 1, 1989
Prostaglandin E1 for primary nonfunction following liver transplantationP D Greig, G M Woolf, M Abecassis, et al.
Transplantation|September 1, 1989
Treatment of primary liver graft nonfunction with prostaglandin E1P D Greig, G M Woolf, S B Sinclair, et al.
The Journal of Surgical Research|June 1, 1987
Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegiaK H Teoh, G T Christakis, R D Weisel, et al.
Pageof 10